stockrowArtiva Biotherapeutics, Inc. (ARTV) vs Palisade Bio, Inc. (PALI)
- Artiva Biotherapeutics, Inc. ARTV 4.15 +0.48%
- Palisade Bio, Inc. PALI 1.13 −2.59%
Artiva Biotherapeutics, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Palisade Bio, Inc. are of similar size ($202.2M and $201.9M). Artiva Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 1.8×. Artiva Biotherapeutics, Inc. has the higher net margin (0.00% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Artiva Biotherapeutics, Inc. leads on 7 and Palisade Bio, Inc. on 4.
Valuation
Profitability
| Metric | ARTV | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 95.63% | 68.51% |
| Operating margin | 0.00% | (4,681.99%) | 0.00% |
| Net margin | 0.00% | (4,230.60%) | 0.00% |
| Free cash flow margin | 0.00% | (2,409.27%) | 0.00% |
| Return on equity | (36.58%) | (51.37%) | (51.96%) |
| Return on assets | (33.76%) | (47.68%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack